Astrana 医疗 ASTH
$34.50 −$4.51 (-11.56%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $34.70 +0.58%
开盘$36.18
昨收$39.01
当日区间$31.46 – $37.03
成交量1.06M
市值$1.70B
市盈率（TTM）31.9
股息率–
ASTH 相关新闻
匹配 Astrana Health 或代码 ASTH 的头条新闻，按最新排序。
- Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
- Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53
- A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53
- Barclays Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $53
- Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $55
- Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55
- BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $65
- TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $50
- Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)
- BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $65 正面
- TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50 正面
- Analysts Are Bullish on These Healthcare Stocks: Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVBP) 正面
- Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $53 正面
- BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50 正面
- Barclays Upgrades Astrana Health(ASTH.US) to Buy Rating, Raises Target Price to $50 正面
暂无评论——快来第一个聊聊 ASTH。
登录后参与讨论。